HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
15h
Zacks Investment Research on MSNGILD Data on Once-Yearly Lenacapavir for HIV Prevention PositiveGilead Sciences, Inc. GILD announced positive data from its ongoing phase I study evaluating pipeline candidate, lenacapavir.
Now the Trump administration has put the brakes on foreign aid while alleging it's wasteful, causing chaos in the system that for over 20 years has kept millions of people alive ...
10h
Queerty on MSNA once-a-year PrEP injection? The results of the first clinical trial look promisingPharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The ...
In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...
The United Nations AIDS agency has warned that more than 6 million lives could be at risk over the next four years if the US government cuts off global funding of HIV/AIDS programmes.
Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...
Tiamat Legion Medusa from Texas, who was born Richard Hernandez, had a dream about a snake bite, which they believe turned ...
Few people under 30 years old understand what AIDS does to the body. The U.S.-led global response to HIV has been so effective that AIDS wards of people wasting away are a vision of the past. Now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results